RSS Amplifier

re:frame · Jul 23, 2026

The FDA just approved two peptides. New voting members all sell them.

0
Sign in to vote or save

Derek Beres · re:frame

The FDA just green-lit the production of two popular peptides by specialized pharmacies even though there’s not a lot of clinical evidence to support their efficacy.

In fact, FDA scientists warned against doing so. As NPR reports:

An analysis presented by FDA scientists didn't support easing restrictions on BPC-157, often used for ulcerative colitis, or KPV, a peptide used for inflammation.

Fewer than 10 human clinical trials on BPC-157 exist. None tracking use beyond 12 weeks. Existing human data is “scant and of low quality,” meaning small, unblinded trials often run by clinics with a financial stake in outcomes.

No large-scale human trials, formal toxicity studies, or published human safety data exist for KPV. Available research suggests a favorable safety profile, but that hasn't been established in clinical trials, and unknowns remain around drug interactions.

After flagging that he was “looking into” removing peptides from the banned list list on Joe Rogan’s podcast, RFK Jr’s FDA appointed eight new voting members to the Pharmacy Compounding Advisory Committee on June 29, with today’s vote in sight.

And that committee voted in favor of compounded peptides by a margin of 8-6.

Could there possibly be any conflicts of interest?

Once again, Kennedy’s promise of making Washington DC less corrupt has proven to do the opposite.

He just now gets to reward the people he wants to elevate.

No posts

Read the original on derekberes.substack.com

Comments

Nothing yet. Say the first thing.

    Sign in to join the conversation.